Beyond the scale, obesity in the age of GLP-1s

Beyond the scale, obesity in the age of GLP-1s

Why are obesity rates rising, and how are GLP‑1 medicines changing the conversation? EMA expert Bart van der Schueren breaks down what we know about obesity as a chronic disease and why weight is about far more than diet and exercise. Watch the full episode on Inside EMA.